Hong Kong stock market scarce "full chain digital health" target Longevity Health (02661) rose more than 120% at the opening, hot market funds favor.

date
09:38 23/12/2025
avatar
GMT Eight
On December 23, the domestic benchmark enterprise in the "AI + Health" track, Easy Health Group (02661), officially listed on the main board of the Hong Kong Stock Exchange.
On December 23, domestic benchmark enterprise in the "AI+ Health" sector, Easy Health Group (02661), officially listed on the main board of the Hong Kong Stock Exchange. Due to the strong market optimism for the digital health sector and fundamental support for the company, the stock price showed strong performance from the opening, with an opening price of HK$50, a 120% increase from the issue price. As a rare "full-chain digital health" target in the Hong Kong stock market, Easy Health Group's impressive performance is attributed to multiple core advantages. At the user level, the platform has accumulated 168.4 million registered users, with 60.4% being the core health consumer group aged 20-45, providing solid support for performance growth. At the technical level, the self-developed AIcare technology stack has been widely used in core scenarios such as content creation, intelligent underwriting, and claims review, with the continuous improvement in the value of clues contributed by AI models and significant effects of technical empowerment. The financial data is also impressive, with a 92.9% year-on-year increase in revenue to 945 million yuan in 2024, and a further 84.7% increase to 656 million yuan in the first half of 2025. The proportion of revenue from health services has reached 76.7%, becoming the absolute core growth engine. Against the backdrop of increasing differentiation in the new stock market in Hong Kong and the popularity of scarce targets, Easy Health Group has successfully attracted funds with its unique advantages of "AI technology + user scale + business loop", laying the foundation for subsequent stock performance. The sponsoring institution stated that the company is in line with the "Healthy China" strategy, with strong growth certainty in the future, and is expected to become a core allocation target in the digital health sector of the Hong Kong stock market.